Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Concerned about being left out of the race to patent the human genetic code? No problem. Just fire up your Web browser, take out your Visa card and head over to The Web site sells gene information for as little as 10 cents per base (the chemical unit of DNA).

Launched in September by Hyseq, a Sunnyvale, Calif., biotech firm, GeneSolutions represents the marriage of two hot technology trends-e-commerce and genome research. According to Hyseq CEO Lewis Gruber, his company had accumulated a vast warehouse of gene data but wanted to focus its efforts on developing a few promising drugs. Gruber says Hyseq decided to throw open its doors and let researchers “purchase the genes on a point-and-click basis.”

The move is part of a familiar sounding e-commerce chain of events. Although Hyseq still hadn’t sold a dime’s worth of DNA-sequence information through the portal as TR went to press, plenty of other companies are also scrambling to stake a claim in gene commerce. Recent entries include Australia’s eBioinformatics and Pangea Systems of Oakland, Calif., which was scheduled to launch a portal called last month.

Pangea’s main business is selling the “bioinformatics” hardware and software that pharmaceutical firms use to mine public and private gene databases for the clues they need to create new drugs. But these costly and sophisticated tools are outside the reach of most scientists, says John Couch, Pangea’s CEO-and so the company decided to broaden its market by taking its business online. With DoubleTwist’s easy-to-use interface, biologists can enter a gene’s DNA code and get back a state-of-the-art analysis. “You need some real specific expertise to get these answers right now,” says Couch. “The notion of our site is to get the power of bioinformatics into the hands of [ordinary] researchers.” Pangea looks to make money by charging fees to heavy users and corporations, as well as by marketing products such as chemical reagents online.

0 comments about this story. Start the discussion »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me